Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2017 1
2020 2
2021 9
2022 4
2023 3
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
A next-generation GMMA-based vaccine candidate to fight shigellosis.
Rossi O, Citiulo F, Giannelli C, Cappelletti E, Gasperini G, Mancini F, Acquaviva A, Raso MM, Sollai L, Alfini R, Aruta MG, Vitali CG, Pizza M, Necchi F, Rappuoli R, Martin LB, Berlanda Scorza F, Colucci AM, Micoli F. Rossi O, et al. Among authors: aruta mg. NPJ Vaccines. 2023 Sep 5;8(1):130. doi: 10.1038/s41541-023-00725-8. NPJ Vaccines. 2023. PMID: 37670042 Free PMC article.
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial.
Hanumunthadu B, Demissie T, Greenland M, Skidmore P, Tanha K, Crocker-Buque T, Owino N, Sciré AS, Crispino C, De Simone D, Benincasa M, Aruta MG, Rossi O, Colucci AM, Berlanda Scorza F, Arora AK, Liu X, Clutterbuck EA, Godfrey L, Canals R, Ramasamy MN; Vacc-iNTS Consortium. Hanumunthadu B, et al. Among authors: aruta mg. EBioMedicine. 2025 Sep;119:105903. doi: 10.1016/j.ebiom.2025.105903. Epub 2025 Sep 3. EBioMedicine. 2025. PMID: 40907249 Free PMC article. Clinical Trial.
GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus.
Palmieri E, Kis Z, Ozanne J, Di Benedetto R, Ricchetti B, Massai L, Carducci M, Oldrini D, Gasperini G, Aruta MG, Rossi O, Kontoravdi C, Shah N, Mawas F, Micoli F. Palmieri E, et al. Among authors: aruta mg. Vaccines (Basel). 2022 Jun 28;10(7):1034. doi: 10.3390/vaccines10071034. Vaccines (Basel). 2022. PMID: 35891202 Free PMC article.
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study.
Leroux-Roels I, Maes C, Mancini F, Jacobs B, Sarakinou E, Alhatemi A, Joye J, Grappi S, Cilio GL, Serry-Bangura A, Vitali CG, Ferruzzi P, Marchetti E, Necchi F, Rappuoli R, De Ryck I, Auerbach J, Colucci AM, Rossi O, Conti V, Scorza FB, Arora AK, Micoli F, Podda A, Nakakana UN; Shigella Project Team. Leroux-Roels I, et al. J Infect Dis. 2024 Oct 16;230(4):e971-e984. doi: 10.1093/infdis/jiae273. J Infect Dis. 2024. PMID: 38853614 Free PMC article. Clinical Trial.
25 results